Multi-line lateral flow immunoassay for the detection and subtyping of breast cancer-derived small extracellular vesicles

Abstract

Cancer cell-derived small extracellular vesicles (sEVs) are new promising biomarkers for improved cancer diagnosis. A multi-line lateral flow immunoassay (LFIA) has been proposed for sensitive detection and subtyping of breast cancer-derived sEVs. The expression of cancer surface biomarkers (EpCAM) was confirmed through colorimetric analysis of cell line-derived sEVs (p = 0.076) and patient samples, highlighting the potential for their use as a clinical aid.

Graphical abstract: Multi-line lateral flow immunoassay for the detection and subtyping of breast cancer-derived small extracellular vesicles

Supplementary files

Article information

Article type
Communication
Submitted
03 Mar 2025
Accepted
13 May 2025
First published
21 May 2025

Chem. Commun., 2025, Advance Article

Multi-line lateral flow immunoassay for the detection and subtyping of breast cancer-derived small extracellular vesicles

C. Duffield, L. M. Rey Gomez, S. S. T. Hnit, W. Zhang, S. C. Tsao, D. W. Inglis and Y. Wang, Chem. Commun., 2025, Advance Article , DOI: 10.1039/D5CC01038A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements